We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Demonstrates Human-Centered Engineering and Automation for Laboratory Testing

By LabMedica International staff writers
Posted on 30 Jul 2024
Print article
Image: Siemens is presenting the latest innovations and trends in clinical diagnostics at ADLM 2024 (Photo courtesy of Siemens Healthineers)
Image: Siemens is presenting the latest innovations and trends in clinical diagnostics at ADLM 2024 (Photo courtesy of Siemens Healthineers)

At the ADLM 2024 Clinical Lab Expo, Siemens Healthineers (Forchheim, Germany) is demonstrating what’s achievable for laboratory testing with human-centered engineering and automation. The company’s new capabilities bring unmatched automation to laboratories of all sizes. Enhancements to the Atellica Portfolio underscore sustainability, leading workflow efficiency, AI-enabled intelligence, and advanced analytics to turn data into practical clinical insights.

Clinical laboratories face universal challenges to operate more efficiently, process more samples, run more reports, or get more productivity from less staff. This friction detracts from the value laboratory staff can contribute to clinicians and patients. Successful automation addresses the specific needs of each lab while standardizing tasks that safeguard quality and safety. Siemens consolidates 25 tasks directly into the Atellica systems, which are on display at ADLM 2024. Chip, sensors, and lines of code work together to help simplify tasks and minimize hands-on time. In minutes, a single technologist can manage calibration and QC, daily sorting, and archiving processes—tasks that historically may have taken hours—to improve throughput and reduce waste. Atellica Integrated Automation, for example, can reduce end-to-end manual workflow steps by 75% and 65% of samples run on Atellica Sample Handler can see faster turnaround times than competitor systems

Attendees to the meeting can also see how the Atellica Portfolio is supporting wider health system efficiencies. The ability to shift employees from location to location is increasingly important to maintain the required staffing to keep laboratories operational. The industry-leading modular and connectivity options offered by Siemens seamlessly integrate advanced automation into small and mega-labs alike. The Atellica Solution and Atellica CI Analyzer offer a consistent user experience so that entry-level professionals and experienced medical technologists can be ready to process samples anywhere in the network. Health systems also benefit from the analyzers’ cost savings and sustainability—they consume the least water compared to other integrated analytical systems and 98.3% of Atellica Solution materials can be recycled.

Additionally, Siemens is introducing visitors to its booth to FlexLab X, the next-generation total lab automation solution by Inpeco. This next-generation automation system aims to redefine automation excellence by offering enhanced flexibility, ease of use, and efficiency. Siemens offers several decentralized testing solutions that enable timely decision-making and treatment. Informatics, emergency, and critical care solutions such as the epoc Blood Analysis System are available for demonstration. Throughout the show, clinical experts from Siemens are presenting more than 30 scientific posters. Research topics include automation and analytical techniques, cardiac markers, clinical and diagnostic immunology, endocrinology and metabolism, pediatric and maternal-fetal medicine, therapeutic drug monitoring and toxicology, and tumor markers and cancer diagnostics.

"Test results are the red thread that informs care decisions. Patients rely on laboratory scientists’ expertise for fast and reliable results and insights. Standing in the way are burdensome, repetitive manual tasks that take significant time but are critical and that’s where our new automation features play an essential role,” said Sharon Bracken, head of Diagnostics for Siemens Healthineers. “Knowing where to start with automation can be overwhelming, so our goal with human-centered engineering is to simplify, allowing the labs we serve to focus on advancing patient care.”

Related Links:
Siemens Healthineers

New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
New
Human Chorionic Gonadotropin Test
Humasis hCG Combo
New
Silver Member
CEA Assay
Carcinoembryonic Antigen Assay

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: TriVerity Test is the first and only molecular blood test that can both identify bacterial and viral infections (Photo courtesy of Inflammatix)

30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease

Despite significant investment in innovation and decades of research, sepsis continues to have a high mortality rate and remains the most expensive diagnosis for healthcare systems. Hospital systems bear... Read more

Industry

view channel
Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)

Medlab Middle East Looks to The Future of Laboratories

The medical laboratory market in the Middle East and Africa (MEA) is expected to experience substantial growth, with projections indicating it could reach USD 473.84 million by 2029, growing at a strong... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.